Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer

NCT00063999 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1381

Enrollment

NETWORK

Sponsor class

Conditions

Recurrent Uterine Corpus Carcinoma
Stage IIIA Uterine Corpus Cancer AJCC v7
Stage IIIB Uterine Corpus Cancer AJCC v7
Stage IIIC Uterine Corpus Cancer AJCC v7
Stage IVA Uterine Corpus Cancer AJCC v7
Stage IVB Uterine Corpus Cancer AJCC v7

Interventions

DRUG: Carboplatin
DRUG: Cisplatin
DRUG: Doxorubicin Hydrochloride
BIOLOGICAL: Filgrastim
OTHER: Laboratory Biomarker Analysis
DRUG: Paclitaxel
BIOLOGICAL: Pegfilgrastim
OTHER: Quality-of-Life Assessment

Sponsor

GOG Foundation

Collaborators

[object Object]